Clopidogrel (clopidogrel): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1564492295

Medication indications

Clopidogrel 75 mg film-coated tablets

Prevention of atherothrombotic events

Clopidogrel is indicated in:

• Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

• Adult patients suffering from acute coronary syndrome:

- Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

- ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

Prevention of atherothrombotic and thromboembolic events in atrial fibrillation

In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

For further information please refer to section 5.1.

Clopidogrel 75 mg Film-coated Tablets

Prevention of atherothrombotic events

Clopidogrel is indicated in:

• Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

• Adult patients suffering from acute coronary syndrome:

- Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

- ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

Prevention of atherothrombotic and thromboembolic events in atrial fibrillation

In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

For further information please refer to section 5.1.

Clopidogrel 75mg Film-coated Tablets

Prevention of atherothrombotic events

Clopidogrel is indicated in:

• Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

• Adult patients suffering from acute coronary syndrome:

- Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

- ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

Prevention of atherothrombotic and thromboembolic events in atrial fibrillation

In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

For further information please refer to section 5.1.


Route of administration: Oral
Molecule: clopidogrel

Patients' opinions on Clopidogrel

In brief

General satisfaction level: 6.33/10 Learn more

Treatment's effectiveness: 7.00/10 Learn more

Ease of use: 7.33/10 Learn more

Adherence to prescription: 7.33/10 Learn more

Detected side effects: 6.00/10 Learn more

Improvement in the quality of life: 6.33/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community


avatar
lesmal • Ambassador
on 04/04/2020

At last I'm able to come off Clopidogrel... Currently taking 37.5mg. and will be pleased to stop taking it. 

One less medication from the many I take daily! 

Your message


avatar
lesmal • Ambassador
on 04/04/2020

I finally got the 'go ahead' from my Neuro-Radiologist advising that I could now stop taking Clopidogrel... This will be done next week, but one has to wean off the medication slowly to do this properly.

I am so pleased to hear this news; one medication less from so many I take per day! 

Your message


avatar
lesmal • Ambassador
on 18/12/2019

I recently saw my Neuro-Radiologist who advised that my blood is too thin now. He cut my dosage of Clopidrogel down to 37.5mgs. Regret, this medication has several side effects. I've also found out that due to low dosage, I've had more seizures. 

Your message


avatar
lesmal • Ambassador
on 25/09/2019

Too soon to tell due to cerebral aneurysm! 

Your message

Members using this Clopidogrel

Conditions related to this medication

See the fact sheet
Fact sheet

Atrial fibrillation

See the fact sheet
See the fact sheet